398
Views
15
CrossRef citations to date
0
Altmetric
Review

Pharmacotherapy of type 2 diabetes in patients with chronic liver disease: focus on nonalcoholic fatty liver disease

, , , &
Pages 1903-1914 | Received 12 Jun 2018, Accepted 28 Sep 2018, Published online: 09 Oct 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Marco Arrese, Francisco Barrera, Nicolas Triantafilo & Juan Pablo Arab. (2019) Concurrent nonalcoholic fatty liver disease and type 2 diabetes: diagnostic and therapeutic considerations. Expert Review of Gastroenterology & Hepatology 13:9, pages 849-866.
Read now

Articles from other publishers (14)

Maria Zachou, Pagona Flevari, Narjes Nasiri-Ansari, Constantinos Varytimiadis, Evangelos Kalaitzakis, Eva Kassi & Theodoros Androutsakos. (2023) The role of anti-diabetic drugs in NAFLD. Have we found the Holy Grail? A narrative review. European Journal of Clinical Pharmacology.
Crossref
Kun Hu, Yongjin Sun, Jie Wang, Shaojun Wu, Jie Ren, Dan Su, Lidan Tang, Jinhong Gong, Hufeng Fang, Shan Xu & Hao Yang. (2023) Integrating network analysis and experimental validation to reveal the mechanism of pinocembrin in alleviating high glucose and free fatty acid-induced lipid accumulation in HepG2 cells. Journal of Functional Foods 110, pages 105879.
Crossref
Jariya Buniam, Piyachat Chansela, Jittima Weerachayaphorn & Vitoon Saengsirisuwan. (2023) Dietary Supplementation with 20-Hydroxyecdysone Ameliorates Hepatic Steatosis and Reduces White Adipose Tissue Mass in Ovariectomized Rats Fed a High-Fat, High-Fructose Diet. Biomedicines 11:7, pages 2071.
Crossref
Dachuan Jin, Zhongfeng Cui, Shunqin Jin, Tao Zhou, Baoqiang Guo, Peng Gao & Guangming Li. (2023) Comparison of efficacy of anti-diabetics on non-diabetic NAFLD: A network meta-analysis. Frontiers in Pharmacology 13.
Crossref
Youn Huh, Yoon Jeong Cho & Ga Eun Nam. (2022) Recent Epidemiology and Risk Factors of Nonalcoholic Fatty Liver Disease. Journal of Obesity & Metabolic Syndrome 31:1, pages 17-27.
Crossref
Alessandro Mantovani & Andrea Dalbeni. (2021) Treatments for NAFLD: State of Art. International Journal of Molecular Sciences 22:5, pages 2350.
Crossref
Wen Guo, Wenjun Tian, Lu Lin & Xiangjin Xu. (2020) Liraglutide or insulin glargine treatments improves hepatic fat in obese patients with type 2 diabetes and nonalcoholic fatty liver disease in twenty-six weeks: A randomized placebo-controlled trial. Diabetes Research and Clinical Practice 170, pages 108487.
Crossref
A. Mantovani, C.D. Byrne, E. Scorletti, C.S. Mantzoros & G. Targher. (2020) Efficacy and safety of anti-hyperglycaemic drugs in patients with non-alcoholic fatty liver disease with or without diabetes: An updated systematic review of randomized controlled trials. Diabetes & Metabolism 46:6, pages 427-441.
Crossref
Alessandro Mantovani, Giovanni Targher & Giacomo Zoppini. (2020) Nonalcoholic Fatty Liver Disease and Implications for Older Adults with Diabetes. Clinics in Geriatric Medicine 36:3, pages 527-547.
Crossref
Vasilios G. Athyros, Stergios A. Polyzos, Jiannis Kountouras, Niki Katsiki, Panagiotis Anagnostis, Michael Doumas & Christos S. Mantzoros. (2020) Non-Alcoholic Fatty Liver Disease Treatment in Patients with Type 2 Diabetes Mellitus; New Kids on the Block. Current Vascular Pharmacology 18:2, pages 172-181.
Crossref
Golnaz Ranjbar, Dimitri P. Mikhailidis & Amirhossein Sahebkar. (2019) Effects of newer antidiabetic drugs on nonalcoholic fatty liver and steatohepatitis: Think out of the box!. Metabolism 101, pages 154001.
Crossref
Hao Yang, Tingting Yang, Cai Heng, Yi Zhou, Zhenzhou Jiang, Xuan Qian, Lei Du, Shiyu Mao, Xiaoxing Yin & Qian Lu. (2019) Quercetin improves nonalcoholic fatty liver by ameliorating inflammation, oxidative stress, and lipid metabolism in db / db mice . Phytotherapy Research 33:12, pages 3140-3152.
Crossref
Niki Katsiki, George Dimitriadis & Dimitri P. Mikhailidis. (2019) Perirenal Adiposity and Other Excessive Intra- and Peri-Organ Fat Depots: What Is the Connection?. Angiology 70:7, pages 581-583.
Crossref
Umair Iqbal, Brandon Perumpail, Daud Akhtar, Donghee Kim & Aijaz Ahmed. (2019) The Epidemiology, Risk Profiling and Diagnostic Challenges of Nonalcoholic Fatty Liver Disease. Medicines 6:1, pages 41.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.